Novo Nordisk
NVO
#105
Rank
A$245.01 B
Marketcap
A$55.03
Share price
-2.57%
Change (1 day)
-39.41%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Quarterly Reports

Thumbnail Novo Nordisk Quarterly Report 2021-q1

Quarterly Report 2021-q1

Language: English

View Quarterly Report
Thumbnail Novo Nordisk Quarterly Report 2020-q1

Quarterly Report 2020-q1

Language: English

View Quarterly Report